Femasys (FEMY) Change in Accured Expenses (2020 - 2026)
Femasys' (FEMY) quarterly Change in Accured Expenses came in at -$193226.0 in Q1 2026, down 1104.35% YoY from $19239.0 in Q1 2025, and down 37546.9% on a QoQ basis from $516.0 in Q4 2025.
Femasys (FEMY) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Change in Accured Expenses data on file, last reported at -$193226.0 in Q1 2026.
- Quarterly Change in Accured Expenses fell 1104.35% year-over-year to -$193226.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$235643.0 (down 1095.7% YoY) and the FY2025 annual result came in at -$23178.0, up 36.62% from the prior year.
- Change in Accured Expenses slipped to -$193226.0 in Q1 2026, from $516.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $874854.0 in Q4 2023 to a low of -$516949.0 in Q2 2024.
- A 5-year average of $39511.7 and a median of $516.0 in 2025 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses sank 63685.36% — and 2025, when it surged 974.58%.
- Tracing FEMY's Change in Accured Expenses over 5 years: stood at -$108739.0 in 2022, then surged by 904.54% to $874854.0 in 2023, then tumbled by 100.01% to -$59.0 in 2024, then surged by 974.58% to $516.0 in 2025, then sank by 37546.9% to -$193226.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$193226.0 (Q1 2026), $516.0 (Q4 2025), and $74603.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 55.00 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 50.56 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 50.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 29.00 Mn |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 | 9,006.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193,226.00 |
| Mar 31, 2026 | -193,226.00 |
| Dec 31, 2025 | 516.00 |
| Dec 31, 2025 | 516.00 |
| Sep 30, 2025 | 74,603.00 |
| Sep 30, 2025 | 74,603.00 |
| Jun 30, 2025 | -117,536.00 |
| Jun 30, 2025 | -117,536.00 |
| Mar 31, 2025 | 19,239.00 |
| Mar 31, 2025 | 19,239.00 |
| Dec 31, 2024 | -59.00 |
| Dec 31, 2024 | -59.00 |
| Sep 30, 2024 | 521,435.00 |
| Sep 30, 2024 | 521,435.00 |
| Jun 30, 2024 | -516,949.00 |
| Jun 30, 2024 | -516,949.00 |
| Mar 31, 2024 | -40,995.00 |
| Mar 31, 2024 | -40,995.00 |
| Dec 31, 2023 | 874,854.00 |
| Dec 31, 2023 | 874,854.00 |